
PS-2020a / part17
.pdf
DICOM PS3.17 2020a - Explanatory Information |
Page 671 |
RRR Measurement Report SR Document for Planar and Volumetric ROI (Informative)
This Annex contains examples of the use of ROI templates within Measurement Report SR Documents.
RRR.1 Measurement Report SR Document Volumetric ROI on CT Example
ThisCTexampledescribestheminimumcontentnecessarytoencodeasinglemeasurement(volume)madefromasinglevolumetric ROI encoded as a single segment that spans two source CT images.
Note
1.References to Segmentation Image or Surface Segmentation objects are encoded as IMAGE references, with a single value specified in Referenced Segment Number.
2.The method of volume calculation is not described in this example.
Table RRR.1-1. Volumetric ROI on CT Example
Node |
Code Meaning of Concept Name |
CodeMeaningorExampleValue |
TID |
|
1 |
Oncology Measurement Report |
|
TID 1500 |
|
1.1 |
LanguageofContentItemandDescendantsEnglish |
TID 1204 |
|
|
1.2 |
Observation Context |
|
TID 1001 |
|
1.2.1 |
Person Observer Name |
Doe^Jane |
TID 1003 |
|
1.3 |
Procedure Reported |
Chest+Abd CT W+WO contr IV TID 1500 |
|
|
1.4 |
Measurements |
|
TID 1500 |
|
1.4.1 |
Measurement Group |
|
TID 1411 |
|
1.4.1.1 |
Tracking Identifier |
Object1 |
TID 1411 |
|
1.4.1.2 |
Tracking Unique Identifier |
1.2.276.0.7230010... |
TID 1411 |
|
1.4.1.3 |
Referenced Segment |
IMAGE - Segmentation, SegmentTID 1411 |
|
|
|
|
#1 |
|
|
1.4.1.4 |
Source image for segmentation |
IMAGE - CT image #1 |
TID 1411 |
|
1.4.1.5 |
Source image for segmentation |
IMAGE - CT image #2 |
TID 1411 |
|
1.4.1.6 |
Volume |
3267.46 mm3 |
TID 1419 |
|
RRR.2 Measurement Report SR Document Volumetric ROI on CT Example
ThisCTexampledescribesasetofmeasurements(volume.longaxisandmeanattenuationcoefficient)madefromasinglevolumetric ROI encoded as a single segment that spans two source CT images, and includes a description of the measurement methods and the finding site, as well as an image library to describe characteristics of the images used, and categorical observations at the measurement group and entire subject level.
Note
1.For a different modality than CT, the choice of measurement for the mean intensity would not be (122713, DCM, "Atten- uation Coefficient").
2.For MR one might use (110852, DCM, "MR signal intensity"), or (110804, DCM, "T1 Weighted MR Signal Intensity"), etc. See also CID 7180 “Abstract Multi-dimensional Image Model Component Semantics” for various appropriate signal intensity types for MR and other modalities.
- Standard -

Page 672 |
DICOM PS3.17 2020a - Explanatory Information |
3.For PET one might use (110821, DCM, "Nuclear Medicine Tomographic Activity"), in which case the specific type of signal would be apparent from the units, e.g., ({SUVbw}g/ml, UCUM, "Standardized Uptake Value body weight") or for activity-concentration, (Bq/ml, UCUM, "Becquerels/milliliter"). See also CID 84 “PET Units”.
4.Care should be taken when selecting modifiers such as (370129005, SCT, "Measurement Method") versus (121401, DCM, "Derivation").
5.The finding site and laterality within the measurement template (TID 1419 “ROI Measurements”) are factored out and shared by both measurements.
6.ThepatternusedfortheimagelibraryusesTID4020“CADImageLibraryEntry”,thoughcommonalitymayberefactored.
7.The length of the long axis of the volumetric ROI is encoded, but the end points of the line segment used to make that measurement are not recorded, since only the volumetric spatial description of TID 1411 is used. For an alternative encoding, see Section RRR.5.
Table RRR.2-1. Volumetric ROI on CT Example
Node |
Code Meaning of Concept Name |
Code Meaning or Example |
TID |
|
|
Value |
|
1 |
Oncology Measurement Report |
|
TID 1500 |
1.1 |
Language of Content Item and |
English |
TID 1204 |
|
Descendants |
|
|
1.2 |
Observation Context |
|
TID 1001 |
1.2.1 |
Person Observer Name |
Doe^Jane |
TID 1003 |
1.3 |
Procedure Reported |
Chest+Abd CT W+WO contr IVTID 1500 |
|
1.4 |
Image Library |
|
TID 1500 |
1.4.1 |
|
IMAGE - CT image #1 |
TID 4020 |
1.4.1.1 |
Study Date |
20030417 |
TID 4020 |
1.4.1.2 |
Study Time |
104607 |
TID 4020 |
1.4.1.3 |
Horizontal Pixel Spacing |
0.810547 mm |
TID 4020 |
1.4.1.j |
... |
... |
TID 4020 |
1.4.1.n |
Pixel Data Columns |
512 pixels |
TID 4020 |
1.4.2 |
|
IMAGE - CT image #2 |
TID 4020 |
1.4.2.j |
... |
... |
TID 4020 |
1.5 |
Measurements |
|
TID 1500 |
1.5.1 |
Measurement Group |
|
TID 1411 |
1.5.1.1 |
Tracking Identifier |
Object1 |
TID 1411 |
1.5.1.2 |
Tracking Unique Identifier |
1.2.276.0.7230010... |
TID 1411 |
1.5.1.3 |
Referenced Segment |
IMAGE-Segmentation,SegmentTID 1411 |
|
|
|
#1 |
|
1.5.1.4 |
Source image for segmentation |
IMAGE - CT image #1 |
TID 1411 |
1.5.1.5 |
Source image for segmentation |
IMAGE - CT image #2 |
TID 1411 |
1.5.1.6 |
Finding Site |
Adrenal Gland |
TID 1419 |
1.5.1.6.1 |
Laterality |
Right |
TID 1419 |
1.5.1.7 |
Volume |
3267.46 mm3 |
TID 1419 |
1.5.1.7.1 |
Measurement Method |
SumofsegmentedvoxelvolumesTID 1419 |
|
|
|
|
CID 7474 |
- Standard -

|
DICOM PS3.17 2020a - Explanatory Information |
Page 673 |
|
Node |
Code Meaning of Concept Name |
Code Meaning or Example |
TID |
|
|
Value |
|
1.5.1.8 |
Long Axis |
9.21 mm |
TID 1419 |
|
|
|
CID 7470 |
1.5.1.8.1 |
Measurement Method |
RECIST 1.1 |
TID 1419 |
|
|
|
CID 6147 |
1.5.1.9 |
Attenuation Coefficient |
70.978 Hounsfield unit |
TID 1419 |
1.5.1.9.1 |
Derivation |
Mean |
TID 1419 |
|
|
|
CID 7464 |
1.5.1.10 |
Necrosis |
Present |
TID 1419 |
1.5.1.11 |
Hemorrhage |
Absent |
TID 1419 |
1.6 |
Qualitative Evaluations |
|
TID 1500 |
1.6.1 |
Renal Vein Involvement |
Absent |
TID 1500 |
RRR.3MeasurementReportSRDocumentPlanarROIonDCE-MRTracerKinetic
Model Example
This DCE-MR example illustrates encoding measurements of mean and standard deviation Ktrans values in a planar ROI.
Note
1.The measurement method and finding site and laterality within the measurement template (TID 1419) are factored out and shared by both measurements.
Table RRR.3-1. Planar ROI on DCE-MR Example
Node |
Code Meaning of Concept Name |
CodeMeaningorExampleValue |
TID |
|
|
|
|
|
CID |
1 |
Oncology Measurement Report |
|
TID 1500 |
|
1.1 |
Language of Content Item and |
English |
TID 1204 |
|
|
Descendants |
|
|
|
1.2 |
Observation Context |
|
TID 1001 |
|
1.2.1 |
Person Observer Name |
Doe^Jane |
TID 1003 |
|
1.3 |
Procedure Reported |
Breast - bilateral MRI dynamic WTID 1500 |
|
|
|
|
contrast IV |
|
|
1.4 |
Measurements |
|
TID 1500 |
|
1.4.1 |
Measurement Group |
|
TID 1411 |
|
1.4.1.1 |
Tracking Identifier |
Object1 |
TID 1411 |
|
1.4.1.2 |
Tracking Unique Identifier |
1.2.276.0.7230010... |
TID 1411 |
|
1.4.1.3 |
Referenced Segment |
IMAGE - Segmentation, SegmentTID 1411 |
|
|
|
|
#1 |
|
|
1.4.1.4 |
Source image for segmentation |
IMAGE - MR image #1 |
TID 1411 |
|
1.4.1.5 |
Measurement Method |
Extended Tofts Model |
TID 1419 |
|
|
|
|
CID 4101 |
|
1.4.1.6 |
Finding Site |
Breast |
TID 1419 |
|
1.4.1.6.1 |
Laterality |
Right |
TID 1419 |
|
- Standard -

Page 674 |
|
DICOM PS3.17 2020a - Explanatory Information |
|
|
Node |
Code Meaning of Concept Name CodeMeaningorExampleValue |
TID |
||
|
|
|
|
CID |
1.4.1.7 |
Ktrans |
0.0185 /min |
TID 1419 |
|
1.4.1.7.1 |
Derivation |
Mean |
TID 1419 |
|
|
|
|
CID 7464 |
|
1.4.1.8 |
Ktrans |
0.0102 /min |
TID 1419 |
|
1.4.1.8.1 |
Derivation |
Standard Deviation |
TID 1419 |
|
|
|
|
CID 7464 |
|
RRR.4MeasurementReportSRDocumentVolumetricandSUVROIonFDGPET
Example
This FDG PET example illustrates encoding measurements of various SUVbw related measurements.
Note
1.The real world value map reference (for intensity, not size measurements) and finding site within the measurement template (TID 1419) are factored out and shared by measurements.
2.The time point is described in this case only with a simple label.
Table RRR.4-1. SUV ROI on FDG PET Example
Node |
Code Meaning of Concept Name Code Meaning or Example Value |
TID |
||
|
|
|
|
CID |
1 |
Oncology Measurement Report |
|
TID 1500 |
|
1.1 |
Language of Content Item and |
English |
TID 1204 |
|
|
Descendants |
|
|
|
1.2 |
Observation Context |
|
TID 1001 |
|
1.2.1 |
Person Observer Name |
Doe^Jane |
TID 1003 |
|
1.3 |
Procedure Reported |
PET/CT FDG imaging of whole |
TID 1500 |
|
|
|
body |
|
|
1.4 |
Measurements |
|
TID 1500 |
|
1.4.1 |
Measurement Group |
|
TID 1411 |
|
1.4.1.1 |
Tracking Identifier |
Liver |
TID 1411 |
|
1.4.1.2 |
Tracking Unique Identifier |
1.2.276.0.7230010... |
TID 1411 |
|
1.4.1.3 |
Time Point |
TP0 |
TID 1502 |
|
1.4.1.4 |
Referenced Segment |
IMAGE - Segmentation, SegmentTID 1411 |
|
|
|
|
#1 |
|
|
1.4.1.5 |
Source image for segmentation |
IMAGE - PET image #1 |
TID 1411 |
|
1.4.1.6 |
Source image for segmentation |
IMAGE - CT image #1 |
TID 1411 |
|
1.4.1.7 |
Finding Site |
Liver |
TID 1419 |
|
1.4.1.8 |
Real World Value Map used for |
RWVM - UID |
TID 1419 |
|
|
measurement |
|
|
|
1.4.1.9 |
SUVbw |
3.90557 {SUVbw}g/ml |
TID 1419 |
|
- Standard -

|
DICOM PS3.17 2020a - Explanatory Information |
|
Page 675 |
|
Node |
Code Meaning of Concept Name Code Meaning or Example Value |
TID |
||
|
|
|
|
CID |
1.4.1.9.1 |
Derivation |
Max |
TID 1419 |
|
|
|
|
CID 7464 |
|
1.4.1.10 |
SUVbw |
3.25653 {SUVbw}g/ml |
TID 1419 |
|
1.4.1.10.1 |
Derivation |
Peak Value Within ROI |
TID 1419 |
|
|
|
|
CID 7464 |
|
1.4.1.11 |
SUVbw |
2.34467 {SUVbw}g/ml |
TID 1419 |
|
1.4.1.11.1 |
Derivation |
Root Mean Square |
TID 1419 |
|
|
|
|
CID 7464 |
|
1.4.1.12 |
Standardized Added Metabolic Activity20400.3 g |
TID 1419 |
|
|
|
(SAM) |
|
CID 7466 |
|
|
|
|
|
|
1.4.1.12.1 |
Measurement Method |
SUV body weight calculation |
TID 1419 |
|
|
|
method |
|
|
1.4.1.13 |
Volume |
395512 mm3 |
TID 1419 |
|
1.4.1.13.1 |
Measurement Method |
Sum of segmented voxel volumesTID 1419 |
|
|
|
|
|
CID 7474 |
|
RRR.5 Measurement Report SR Document Volumetric ROI with RECIST Linear Distance Specified by Coordinates on CT Example
ThisCTexampledescribesasetofmeasurements(volume,longaxis(RECIST),shortaxis(WHObi-dimensional)andmeanattenuation coefficient) made from a single volumetric ROI encoded as a single segment, including specification of the end points of the line segment used to make the linear distance measurements.
Note
1.The lengths of the long axis and the short axis of the lesion are not encoded as characteristics of the volumetric ROI, but rather the long axis and the short axis are encoded explicitly as the end points of line segments used to make those measurements. The commonality of the Tracking Unique Identifier establishes that they are measurements of the same ROI. If multiple measurements were to be made of the same ROI over time or by different observers, other content items such as those related to Timepoint, Activity Session and Observer may be used. For an alternative encoding, see Section RRR.2.
2.The pattern of using multiple sibling linear distance measurements within TID 1419 “ROI Measurements” is similar to and not incompatible with the pattern used for length, width and height in the OB/GYN Ultrasound template TID 5016 “LWH Volume Group”.
3.The Finding Site information is duplicated in the second measurement template invocation in this example, though it is not required to be.
Table RRR.5-1. Volumetric ROI on CT Example
Node |
CodeMeaningofConceptName Code Meaning or Example Value |
TID |
|
1 |
Oncology Measurement Report |
|
TID 1500 |
... |
... |
... |
... |
1.5 |
Measurements |
|
TID 1500 |
1.5.1 |
Measurement Group |
|
TID 1411 |
- Standard -

Page 676 |
DICOM PS3.17 2020a - Explanatory Information |
|
|
Node |
CodeMeaningofConceptName Code Meaning or Example Value |
TID |
|
1.5.1.1 |
Tracking Identifier |
Object1 (same for both Measurement |
TID 1411 |
|
|
Groups) |
|
1.5.1.2 |
Tracking Unique Identifier |
1.2.276.0.7230010... (same for both |
TID 1411 |
|
|
Measurement Groups) |
|
1.5.1.3 |
Referenced Segment |
IMAGE - Segmentation, Segment #1 |
TID 1411 |
1.5.1.4 |
Source image for segmentation |
IMAGE - CT image #1 |
TID 1411 |
1.5.1.5 |
Source image for segmentation |
IMAGE - CT image #2 |
TID 1411 |
1.5.1.6 |
Finding Site |
AdrenalGland(sameforbothMeasurementTID 1419 |
|
|
|
Groups) |
|
1.5.1.6.1 |
Laterality |
Right(sameforbothMeasurementGroups)TID 1419 |
|
1.5.1.7 |
Volume |
3267.46 mm3 |
TID 1419 |
1.5.1.7.1 |
Measurement Method |
Sum of segmented voxel volumes |
TID 1419 |
|
|
|
CID 7474 |
1.5.1.8 |
Attenuation Coefficient |
70.978 Hounsfield unit |
TID 1419 |
1.5.1.8.1 |
Derivation |
Mean |
TID 1419 |
|
|
|
CID 7464 |
1.6.1 |
Measurement Group |
|
TID 1501 |
1.6.1.1 |
Tracking Identifier |
Object1 (same for both Measurement |
TID 1501 |
|
|
Groups) |
|
1.6.1.2 |
Tracking Unique Identifier |
1.2.276.0.7230010... (same for both |
TID 1501 |
|
|
Measurement Groups) |
|
1.6.1.3 |
Finding Site |
AdrenalGland(sameforbothMeasurementTID 1501 |
|
|
|
Groups) |
|
1.6.1.3.1 |
Laterality |
Right(sameforbothMeasurementGroups)TID 1501 |
|
1.6.1.4 |
Long Axis |
9.21 mm |
TID 300 |
|
|
|
CID 7470 |
1.6.1.4.1 |
Measurement Method |
RECIST 1.1 |
TID 300 |
|
|
|
CID 6147 |
1.6.1.4.2 |
Source of Measurement |
SCOORDGraphicTypePOLYLINEwithtwoTID 320 |
|
|
|
coordinates, the beginning and end of a line |
|
|
|
segment |
CID 7470 |
1.6.1.4.2.1 |
(none) |
IMAGE - CT image #1 |
TID 320 |
1.6.1.5 |
Short Axis |
6.8 mm |
TID 300 |
|
|
|
CID 7470 |
1.6.1.5.1 |
Measurement Method |
WHO |
TID 300 |
|
|
|
CID 6147 |
1.6.1.5.2 |
Source of Measurement |
SCOORDGraphicTypePOLYLINEwithtwoTID 320 |
|
|
|
coordinates, the beginning and end of a line |
|
|
|
segment |
CID 7470 |
1.6.1.5.2.1 |
(none) |
IMAGE - CT image #1 |
TID 320 |
- Standard -

DICOM PS3.17 2020a - Explanatory Information |
Page 677 |
SSSUseofImageLibrariesinSRDocuments (Informative)
This Annex contains examples of the use of Image Library templates within SR Documents.
SSS.1 Image Library for PET-CT Example
This PET-CT example dillustrates an Image Library in which Attributes of images for two modalities are described, with common At- tributes factored out of the individual image references.
Note
1.OnlytheAttributesofrelevancetoSUVandspatialmeasurementsareincluded,notacompletedescriptionofallaspects of acquisition.
2.Only two images for each modality are described, rather than all slices acquired, since it is usually only necessary to describe images that are referenced elsewhere in the SR content tree, e.g., on which a region of interest is specified from which measurements are made.
Table SSS.1-1. Image Library for PET-CT Example
Node |
Code Meaning of Concept Name |
CodeMeaningorExample |
TID |
|
|
|
Value |
|
|
1.n |
Image Library |
|
TID 1600 |
|
1.n.1 |
Image Library Group |
|
TID 1600 |
|
1.n.1.1 |
Modality |
PET |
TID 1602 |
|
1.n.1.2 |
Target Region |
Whole Body |
TID 1602 |
|
1.n.1.3 |
Study Date |
20030417 |
TID 1602 |
|
1.n.1.4 |
Acquisition Date |
20030417 |
TID 1602 |
|
1.n.1.5 |
Acquisition Time |
094513 |
TID 1602 |
|
1.n.1.6 |
Frame of Reference UID |
1.2.3.xyz |
TID 1602 |
|
1.n.1.7 |
Pixel Data Rows |
128 |
TID 1602 |
|
1.n.1.8 |
Pixel Data Columns |
128 |
TID 1602 |
|
1.n.1.9 |
Horizontal Pixel Spacing |
4.0 mm |
TID 1604 |
|
1.n.1.10 |
Vertical Pixel Spacing |
4.0 mm |
TID 1604 |
|
1.n.1.11 |
Spacing Between Slices |
4.0 mm |
TID 1604 |
|
1.n.1.12 |
Slice Thickness |
4.0 mm |
TID 1604 |
|
1.n.1.13 |
Image Orientation (Patient) Row X |
1 |
TID 1604 |
|
1.n.1.14 |
Image Orientation (Patient) Row Y |
0 |
TID 1604 |
|
1.n.1.15 |
Image Orientation (Patient) Row Z |
0 |
TID 1604 |
|
1.n.1.16 |
Image Orientation (Patient) Column X |
0 |
TID 1604 |
|
1.n.1.17 |
Image Orientation (Patient) Column Y |
1 |
TID 1604 |
|
1.n.1.18 |
Image Orientation (Patient) Column Z |
0 |
TID 1604 |
|
1.n.1.19 |
Radionuclide |
^18^Fluorine |
TID 1607 |
|
1.n.1.20 |
Radiopharmaceutical agent |
Fluorodeoxyglucose F^18^TID 1607 |
|
|
1.n.1.21 |
Radiopharmaceutical Start DateTime |
20030417084513 |
TID 1607 |
|
1.n.1.22 |
Radionuclide Total Dose |
277000000 Bq |
TID 1607 |
|
- Standard -

Page 678 |
DICOM PS3.17 2020a - Explanatory Information |
|
|
|
Node |
Code Meaning of Concept Name |
CodeMeaningorExample |
TID |
|
|
|
Value |
|
|
1.n.1.23 |
PET Radionuclide Incubation Time |
60 min |
TID 1607 |
|
1.n.1.24 |
Glucose |
5.5 mmol/l |
TID 1607 |
|
1.n.1.24.1 |
Glucose Measurement Date |
20030417 |
TID 1607 |
|
1.n.1.24.2 |
Glucose Measurement Time |
083043 |
TID 1607 |
|
1.n.1.25 |
|
IMAGE - PET image #1 |
TID 1601 |
|
1.n.1.25.1 |
Image Position (Patient) X |
-288.0 |
TID 1604 |
|
1.n.1.25.2 |
Image Position (Patient) Y |
288.0 |
TID 1604 |
|
1.n.1.25.3 |
Image Position (Patient) Z |
136.0 |
TID 1604 |
|
1.n.1.26 |
|
IMAGE - PET image #2 |
TID 1601 |
|
1.n.1.26.1 |
Image Position (Patient) X |
-288.0 |
TID 1604 |
|
1.n.1.26.2 |
Image Position (Patient) Y |
288.0 |
TID 1604 |
|
1.n.1.26.3 |
Image Position (Patient) Z |
140.0 |
TID 1604 |
|
1.n.2 |
Image Library Group |
|
TID 1600 |
|
1.n.2.1 |
Modality |
CT |
TID 1602 |
|
1.n.2.2 |
Target Region |
Whole Body |
TID 1602 |
|
1.n.2.3 |
Study Date |
20030417 |
TID 1602 |
|
1.n.2.4 |
Frame of Reference UID |
1.2.3.xyz |
TID 1602 |
|
1.n.2.5 |
Pixel Data Rows |
512 |
TID 1602 |
|
1.n.2.6 |
Pixel Data Columns |
512 |
TID 1602 |
|
1.n.2.7 |
Horizontal Pixel Spacing |
1.171875 mm |
TID 1604 |
|
1.n.2.8 |
Vertical Pixel Spacing |
1.171875 mm |
TID 1604 |
|
1.n.2.9 |
Spacing Between Slices |
4 mm |
TID 1604 |
|
1.n.2.10 |
Slice Thickness |
4 mm |
TID 1604 |
|
1.n.2.11 |
Image Orientation (Patient) Row X |
1 |
TID 1604 |
|
1.n.2.12 |
Image Orientation (Patient) Row Y |
0 |
TID 1604 |
|
1.n.2.13 |
Image Orientation (Patient) Row Z |
0 |
TID 1604 |
|
1.n.2.14 |
Image Orientation (Patient) Column X |
0 |
TID 1604 |
|
1.n.2.15 |
Image Orientation (Patient) Column Y |
1 |
TID 1604 |
|
1.n.2.16 |
Image Orientation (Patient) Column Z |
0 |
TID 1604 |
|
1.n.2.17 |
CTAcquisition Type |
Spiral Acquisition |
TID 1605 |
|
1.n.2.18 |
Reconstruction Algorithm |
Filtered Back Projection |
TID 1605 |
|
1.n.2.19 |
|
IMAGE - CT image #1 |
TID 1601 |
|
1.n.2.19.1 |
Image Position (Patient) X |
-288.0 |
TID 1604 |
|
1.n.2.19.2 |
Image Position (Patient) Y |
288.0 |
TID 1604 |
|
1.n.2.19.3 |
Image Position (Patient) Z |
136.0 |
TID 1604 |
|
1.n.2.20 |
|
IMAGE - CT image #2 |
TID 1601 |
|
1.n.2.20.1 |
Image Position (Patient) X |
-288.0 |
TID 1604 |
|
1.n.2.20.2 |
Image Position (Patient) Y |
288.0 |
TID 1604 |
|
1.n.2.20.3 |
Image Position (Patient) Z |
140.0 |
TID 1604 |
|
- Standard -

DICOM PS3.17 2020a - Explanatory Information |
Page 679 |
TTT X-Ray 3D Angiographic Image Encoding
Examples (Informative)
TTT.1 General Concepts of X-Ray 3D Angiography
This chapter describes the general concepts of the X-Ray 3D Angiography: the acquisition of the projection images, the 3D recon- struction, and the encoding of the X-Ray 3D Angiographic Image SOP instances. They provide better understanding of the different application cases in the rest of this Annex.
TTT.1.1 Process of Creating An X-Ray 3D Angiography
Two main steps are involved in the process of creating an X-Ray 3D Angiographic Instance: The acquisition of 2D projections and the 3D reconstruction of the volume.
X-Ray Equipment |
3D Reconstruction Application |
Acquisition Context |
3D Reconstruction |
X-Ray Acquisition |
3D Reconstruction |
Parameters |
Parameters |
2D |
3D |
Projection |
Volume |
X-Ray 3D Angiography
Instance
Figure TTT.1.1-1. Process flow of the X-Ray 3D Angiographic Volume Creation
TTT.1.1.1 Acquisition of 2D Projections
The X-Ray equipment acquires 2D projections at different angles. The Acquisition Context describes the technical parameters of a set of 2D projection acquisitions that are used to perform a 3D reconstruction. In the scope of the X-Ray 3D Angiographic SOP Class, all the projections of an Acquisition Context share common parameter values, such as:
•Detector settings, anti-scatter grid, field of view characteristics
•Distances from the X-Ray source to the Isocenter and to the detector, table position and table angles
•Focal spot, spectral filters
•Contrast injection details
If one value of such common parameters changes during the acquisition of the projections, then more than one Acquisition Context will be defined.
TypicallytheprojectionsofanAcquisitionContextaretheresultofarotationalacquisitionwheretheX-Raypositionerfollowsacircular trajectory. However, it is possible to define an Acquisition Context as the set of multiple projections at different X-Ray incidences without a particular spatial trajectory.
An Acquisition Context is characterized by a period of time in which all the projections are acquired. Some other parameters are used to describe the Acquisition Context: start and end DateTime, average exposure techniques (mA, kVp, exposure duration, etc.), posi- tioner start, end and increment angles.
Additionally, other technical parameters that change at each projection can be documented in the X-Ray 3D Angiographic SOP Class on a per-projection basis:
- Standard -

Page 680 |
DICOM PS3.17 2020a - Explanatory Information |
•kVp, mA, exposure duration •Collimator shape and dimensions •X-Ray positioner angles
TTT.1.1.2 3D Reconstruction
The 3D Reconstruction Application performing the 3D Reconstruction can be located in the same X-Ray equipment or in another workstation.
A 3D Reconstruction in the scope of the X-Ray 3D Angiographic SOP Class is the creation of one X-Ray 3D Angiographic volume fromasetofprojectionsfromoneormoreAcquisitionContext(s).Therefore,one3DReconstructioninthisscopereferstotheresulting volume, and not to the application logic to process the projections. This application logic is out of the scope of this SOP Class, the same encoding will result whether several 3D Reconstructions are performed in a single or in multiple application steps to create several volumes (e.g., low and high resolution volumes) from the same set of projections.
One 3D Reconstruction is characterized by some parameters like name, version, manufacturer, description and the type of algorithm used to process the projections.
The 3D Reconstruction can use one or more Acquisition Contexts to generate one single X-Ray 3D Angiographic Volume. Several 3D Reconstructions can be encoded in one single X-Ray 3D Angiographic Instance.
TTT.1.2 X-Ray 3D Angiographic Real World Entities Relationships
This section describes the relationships between the real world entities involved in X-Ray 3D Angiography.
The X-Ray equipment creates one or more acquisition contexts (i.e., one or more rotational acquisitions with different technical parameters). The projections can be kept internal to the equipment (i.e., not exported outside the equipment) or can be encoded as DICOMinstances.InthescopeoftheX-Ray3DAngiographicSOPClass,theprojectionscanbeencodedeitherasX-RayAngiography SOP Class or Enhanced XA SOP Class.
If the projections are encoded as DICOM Instances, they can be referenced in the X-Ray 3D Angiographic image as Contributing Sources. Each Acquisition Context refers to all the DICOM instances involved in that context. If the projections are kept internal to the equipment, the X-Ray 3D Angiographic image can still describe the technical parameters of each acquisition context without ref- erencing any DICOM instance.
The 3D Reconstruction Application creates one or more 3D Reconstructions, each 3D Reconstruction uses one or more Acquisition Contexts. One or more 3D Reconstructions can be encoded in one single X-Ray 3D Angiographic Instance.
X-Ray Equipment |
|
3D Reconstruction |
||
|
Application |
|||
|
|
|
||
|
|
|
|
|
|
|
|
|
|
creates |
|
creates |
|
Acquisition Context |
|
consists of |
is encoded in |
is used by |
3D Reconstruction
is encoded in |
consists of |
X-Ray 2D Angiography |
|
(Multiframe 2D) X-Ray |
|
X-Ray 3D Angiography |
|
X-Ray 3D Angiographic |
Projection |
|
Angiography Instance |
|
Instance |
|
Volume |
Figure TTT.1.2-1. Relationship between the creation of 2D and 3D Instances
TTT.1.3 X-Ray 3D Angiographic Pixel Data Characterization
Similarly to other 3D modalities like CT or MR, the X-Ray 3D Angiographic image is generated from original source data (i.e., original projections) which can be kept internal to the equipment. In this sense, the 3D data resulting from the reconstruction of the original
- Standard -